Pharmacokinetics of factor VIII and factor IX
- 22 April 2003
- journal article
- review article
- Published by Wiley in Haemophilia
- Vol. 9 (s1), 94-100
- https://doi.org/10.1046/j.1365-2516.9.s1.8.x
Abstract
Summary. A survey of principal pharmacokinetic (PK) studies on factor VIII (FVIII) and factor IX (FIX) plasma‐ and rDNA‐derived concentrates, analysed by means of the PKRD program, has been performed. Notwithstanding the accurate definition of the study design, released in 1991 by the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (SSC‐ISTH), a large variability of PK parameters has been pointed out. In the majority of the PK studies, the size of the population is small. In this situation, a careful individualization of haemophilia therapy is strongly recommended. The tailored prediction of loading and maintenance dosages and the need for strict control of trough FVIII/IX levels are mandatory not only to decrease the risk of bleeds but also to spare financial resources. Recently, the old problem of FVIII assay standardization has again become a concern among physicians, especially after the introduction of B‐domain deleted rFVIII concentrate. The discrepancies between the widely used one‐stage clotting assay and the chromogenic substrate assay seem to be solved by the introduction of a product‐specific laboratory standard.Keywords
This publication has 35 references indexed in Scilit:
- Kinetic evaluation of four Factor VIII concentrates by model-independent methodsScandinavian Journal of Haematology, 2009
- Standardization and AssaySeminars in Thrombosis and Hemostasis, 1993
- Pharmacokinetics of Factor VIII in HumansClinical Pharmacokinetics, 1992
- Potency of high purity factor VIII concentratesThe Lancet, 1990
- Evaluation of factor VIII pharmacokinetics in hemophilia‐A subjects undergoing surgery and description of a nomogram for dosing calculationsAmerican Journal of Hematology, 1989
- Clinical Pharmacokinetics of Factor VIII in Patients with Classic HaemophiliaClinical Pharmacokinetics, 1987
- A calculator program for clinical application of the Bayesian method of predicting plasma drug levelsComputer Programs in Biomedicine, 1985
- Calculations of Factor VIII in vivo Recovery and Half‐lifeScandinavian Journal of Haematology, 1984
- Discrepancy between One-stage and Two-stage Assay of Factor VIII:CBritish Journal of Haematology, 1978
- Activated Coagulation Factors: In-Vivo and in-Vitro StudiesBritish Journal of Haematology, 1969